提供来自世界经济和金融领域的
最新信息
(RTTNews) - Below are the earnings highlights for Bristol-Myers Squibb Co. (BMY):
Earnings: -$11.91 billion in Q1 vs. $2.26 billion in the same period last year. EPS: -$5.89 in Q1 vs. $1.07 in the same period last year. Excluding items, Bristol-Myers Squibb Co. reported adjusted earnings of -$8.91 billion or -$4.40 per share for the period.
Analysts projected -$4.44 per share Revenue: $11.87 billion in Q1 vs. $11.34 billion in the same period last year.
-Guidance: Full year EPS guidance: $0.40 - $0.70
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
© 2024 Lime Trading (CY) Ltd
Lime Trading (CY) Ltd 由塞浦路斯证券交易委员会根据2015年9月25日发布的第281/15号许可证授权和监管。“Just2Trade”商标归LimeTrading(CY)有限公司所有。
注册号码: HE 341520
地址: Lime Trading (CY) Ltd
Magnum Business Center, Office 4B, Spyrou Kyprianou Avenue 78
Limassol 3076, Cyprus
免责声明:
本网站上的所有信息和材料未经许可不得使用。更多信息,请联系公司。
在金融市场上交易存在风险。投资产品可能会升值也可能会贬值,投资者可能会损失所有的本金。在涉及有杠杆的产品时,损失可能会大于初始本金。在金融市场上交易的风险信息可以在此查看 全面风险披露。.